Valneva SE
NASDAQ:VALN · NASDAQ Global Select
+$0.01 today
Vol 0.01M · Avg 0.09M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-3.76%
Period High
$12.20
Period Low
$5.17
Latest
$5.38
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP
$1.48B
Iovance Biotherapeutics, Inc.
NASDAQ:IOVA
$1.40B
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX
$1.38B
MeiraGTx Holdings plc
NASDAQ:MGTX
$1.03B
Replimune Group, Inc.
NASDAQ:REPL
$835.63M
Geron Corporation
NASDAQ:GERN
$833.98M
Astria Therapeutics, Inc.
ATXS
$718.13M
Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
$572.90M
Arvinas, Inc.
NASDAQ:ARVN
$487.14M
What is the latest VALN filing?
The latest filing shown is 424B3 dated Jun 16, 2026.
How many recent filings does VALN have?
Intrinsic Alpha currently shows 20 recent filings for VALN.
Explore More
Continue the stock analysis
Jump to another research area for this company.